These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4617581)

  • 1. Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.
    Harthon L; Svedmyr N
    Atherosclerosis; 1974; 20(1):65-8. PubMed ID: 4617581
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
    Brattsand R
    Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of nicotinamide and nicotinic acid to hypolipidemia.
    Dalton C; VanTrabert TC; Dwyer JX
    Biochem Pharmacol; 1970 Sep; 19(9):2609-19. PubMed ID: 4249087
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentaerythritoltetranicotinate (Perycit) in the treatment of hypercholesterolaemia.
    Sigroth K
    Acta Med Scand; 1968 Oct; 184(4):269-73. PubMed ID: 5710032
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of niceritrol (pentaerythritoltetranicotinate) on experimental atherosclerosis in cholesterol-fed rabbits at different levels of plasma cholesterol.
    Brattsand R
    Acta Pharmacol Toxicol (Copenh); 1975 Jan; 36(1):39-55. PubMed ID: 1173722
    [No Abstract]   [Full Text] [Related]  

  • 7. 1 Carbon 14-labeled palmitic acid metabolism in fasted, lactating goats following nicotinic acid administration.
    Waterman R; Schultz LH
    J Dairy Sci; 1973 Dec; 56(12):1569-74. PubMed ID: 4797390
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on the cholesterol-lowering mechanism of nicotinic acid and nicotinyl alcohol tartrate.
    Alton C; Kowalski C; Mallon J; Marschhaus C
    J Atheroscler Res; 1968; 8(2):265-76. PubMed ID: 5664196
    [No Abstract]   [Full Text] [Related]  

  • 9. On the absorption, excretion and metabolism of pentaerythritoltetranicotinate.
    Harthon L; Sigroth K
    Arzneimittelforschung; 1974 Oct; 24(10):1688-92. PubMed ID: 4373013
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(1):61-73. PubMed ID: 4359183
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1975; 22(1):91-101. PubMed ID: 1098680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of nicotinic acid compounds in niceritrol-treated rabbits.
    Brattsand R; Harthon L
    Acta Pharmacol Toxicol (Copenh); 1975 Mar; 36(3):203-14. PubMed ID: 124527
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A; Criscuoli M; Biagi M; Murmann W
    J Pharm Pharmacol; 1983 Sep; 35(9):571-5. PubMed ID: 6138406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man.
    Svedmyr N; Harthon L; Lundholm L
    Clin Pharmacol Ther; 1969; 10(4):559-70. PubMed ID: 5793759
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic and circulatory effects in man of nicotinic acid and an ester of nicotinic acid (pentaerythritoltetranicotinate-8AL-Bofors).
    Svedmyr N
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:29. PubMed ID: 5630934
    [No Abstract]   [Full Text] [Related]  

  • 16. [Daily profile of blood lipids under standardized diet with and without nicotinic acid].
    Mühlfellner G; Mühlfellner O; Zöfel P; Kaffarnik H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():810-2. PubMed ID: 1029288
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of simfibrate on post-heparin lipoprotein lipase].
    Cavallini L; Lucchetti G; Marchi S; Guglielmini R
    Clin Ter; 1980 Jan; 92(1):25-31. PubMed ID: 7004746
    [No Abstract]   [Full Text] [Related]  

  • 19. Lowering of serum lipid levels by "masked" nicotinic acid derivatives.
    Bailey DM; Wood D; Johnson RE; McAuliff JP; Bradford JC; Arnold A
    J Med Chem; 1972 Apr; 15(4):344-8. PubMed ID: 5019547
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of nicotinic acid on individual plasma phospholipids in hypercholesterolemic subjects.
    Vikrot O; Berlin R; Oldfelt CO
    Acta Med Scand; 1971; 190(1-2):133-6. PubMed ID: 5099122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.